VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > GrahamB on ignore

<< Previous

Bullboard Posts

Next >>

Comment by GrahamBon Jan 22, 2021 8:26pm

335 Views

Post# 32366438

RE:GrahamB on ignore

O12009 wrote: If you went to make money in this stock put GrahamB on ignore, it truly cleans up the board. I'm a long timer here and I have watched this stock go from .70 to .06
G.A. Took back over this company last year the same as when Steve Jobs took back over Apple. We will be above $1 in February $2 by March and after that a buyout. The only reason this stock doesn't keep going up after that is because George is happy to build value and sell them so that everybody gets a deal. If you want more of a return the a 10 bagger , buy the company that buys VPT technology, AI is the way of the future.

A quick scan through your posts would lead to the conclusion your predictions are not very accurate , including predictions on news releases sales and price predictions
You made a 2.00 call before: